CXCL9 and neoplasm: The mechanisms of anti‐tumour activity include induction of tumour derived cytokines (CXCL9 and 10) which attract Th‐1 cells (Kryczek et al., 2009), and subsequently, CD8+ lymphocytes and NK cells (Asadzadeh et al., 2017).